Evidence map›Paper›PMID 18848350›Full record

Trial reportThe Journal of allergy and clinical immunology2008

Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program.

Sunita Sharma, Augusto A Litonjua, Kelan G Tantisira, Anne L Fuhlbrigge, Stanley J Szefler, Robert C Strunk, Robert S Zeiger, Amy J Murphy, Scott T Weiss, Childhood Asthma Management Program Research Group

Registry-linked trialOpen access · greenAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01500525 (A Prospective Observational Study in a Tertiary Pediatric Hospital in Beijing to Understand the Accuracy of Bronchodilator Response), which is not on this map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01500525 completednot on this mapstarted 2011, after this paper: background citation

A Prospective Observational Study in a Tertiary Pediatric Hospital in Beijing to Understand the Accuracy of Bronchodilator Response (BDR) in Chinese Controller Naive Asthmatic Children Between the Age of 4~12 Years Old

TypeobservationalSponsorCapital Institute of Pediatrics, ChinaRan2011 to 2015Enrolled587ConditionsAsthma
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Nedocromil sodium for chronic asthma in children.The Cochrane database of systematic reviews · 2006
    Pooled it
  3. Predictors of response to tiotropium versus salmeterol in asthmatic adults.The Journal of allergy and clinical immunology · 2013
    Trial
  4. Diagnostic accuracy of the bronchodilator response in children.The Journal of allergy and clinical immunology · 2013
    Trial
  5. Effect of vitamin D and inhaled corticosteroid treatment on lung function in children.American journal of respiratory and critical care medicine · 2012
    Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Differential long-term regulation of TAS2R14 by structurally distinct agonists.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  12. Article
  13. Article
  14. Novel eosinophilic gene expression networks associated with IgE in two distinct asthma populations.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2018
    Article
  15. Article
  16. Article
  17. Association of FEF25%-75% and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2016
    Article
  18. Article
  19. Stress and Bronchodilator Response in Children with Asthma.American journal of respiratory and critical care medicine · 2015
    Article
  20. Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation.European respiratory review : an official journal of the European Respiratory Society · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Sunita SharmaChanning Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. ssharma4@partners.org
Augusto A Litonjua
Kelan G Tantisira
Anne L Fuhlbrigge
Stanley J Szefler
Robert C Strunk
Robert S Zeiger
Amy J Murphy
Scott T Weiss
Childhood Asthma Management Program Research Group
Brigham and Women's Hospital · USHarvard University · USKaiser Permanente San Diego Medical Center · USUniversity of Colorado Denver · USWashington University in St. Louis · US

Funding

ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI WALDERS, NATALIE · 1985 to 2008
$52.6M
THE PHARMACOGENETICS OF ASTHMA TREATMENTU01HL065899 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI TANTISIRA, KELAN G, WEISS, SCOTT T · 2000 to 2014
$38.5M
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMESM01RR000036 · NCRR · WASHINGTON UNIVERSITY · PI POLONSKY, KENNETH S · 1985 to 2007
$25.4M
ZINC THERAPY FOR SCLERODERMA--PHASE I STUDYM01RR002719 · NCRR · JOHNS HOPKINS UNIVERSITY · PI EARLEY, CHRISTOPHER J · 1986 to 2007
$20.2M
SYSTEMS APPROACHES TO THE EPIDEMIOLOGY, GENETICS AND GENOMICS OF LUNG DISEASEST32HL007427 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI DAWN L DEMEO, Edwin K Silverman · 1985 to 2026
$13.6M
Statistical GeneticsP01HL083069 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 2007 to 2011
$12.2M
CAMP Continuation Study/Phase 3U01HL075419 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI FUHLBRIGGE, ANNE L · 2003 to 2010
$2.0M
CLINICAL CENTER FOR CAMPN01HR016049 · HR · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 1991 to 2000
$1.0M
CLINICAL COORDINATING CENTER FOR CAMPN01HR016044 · HR · JOHNS HOPKINS UNIVERSITY · PI TONASCIA, JAMES A · 1991 to 2006
$729k
CLINICAL CENTER FOR CAMPN01HR016051 · HR · WASHINGTON UNIVERSITY · PI STRUNK, ROBERT C · 1991 to 2000
$0k
CLINICAL CENTER FOR CAMPN01HR016048 · HR · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J · 1991 to 2000
$0k
CLINICAL CENTER FOR CAMPN01HR016047 · HR · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI MACLUSKY, IAN B · 1991 to 2000
$0k
NCRR NIH HHS M01 RR000036NCRR NIH HHS M01 RR000051NCRR NIH HHS M01RR00051NCRR NIH HHS M01 RR002719NCRR NIH HHS M01RR0099718-24NCRR NIH HHS M01RR02719-14NCRR NIH HHS RR00036NHLBI NIH HHS N01 HR016044NHLBI NIH HHS N01-HR-16044NHLBI NIH HHS N01-HR-16045NHLBI NIH HHS N01-HR-16046NHLBI NIH HHS N01-HR-16047NHLBI NIH HHS N01-HR-16048NHLBI NIH HHS N01-HR-16049NHLBI NIH HHS N01-HR-16050NHLBI NIH HHS N01-HR-16051NHLBI NIH HHS N01-HR-16052NHLBI NIH HHS P01 HL083069NHLBI NIH HHS T32 HL007427NHLBI NIH HHS T32 HL07427NHLBI NIH HHS U01 HL065899NHLBI NIH HHS U01 HL075419NHLBI NIH HHS U01 HL65899
6 · The paper itself

Abstract

backgroundAmong asthmatic subjects, bronchodilator response (BDR) to inhaled beta(2)-adrenergic agonists is variable, and the significance of a consistent response over time is unknown.

objectiveWe assessed baseline clinical variables and determined the clinical outcomes associated with a consistently positive BDR over 4 years in children with mild-to-moderate persistent asthma.

methodsIn the 1041 participants in the Childhood Asthma Management Program, subjects with a change in FEV(1) of 12% or greater (and 200 mL) after inhaled beta(2)-agonist administration at each of their yearly follow-up visits (consistent BDR) were compared with those who did not have a consistent BDR.

resultsWe identified 52 children with consistent BDRs over the 4-year trial. Multivariable logistic regression modeling demonstrated that lower baseline prebronchodilator FEV(1) values (odds ratio, 0.71; P < .0001), higher log10 IgE levels (odds ratio, 1.97; P = .002), and lack of treatment with inhaled corticosteroids (odds ratio, 0.31; P = .009) were associated with a consistent BDR. Individuals who had a consistent BDR had more hospital visits (P = .007), required more prednisone bursts (P = .0007), had increased nocturnal awakenings caused by asthma (P < .0001), and missed more days of school (P = .03) than nonresponders during the 4-year follow-up.

conclusionsWe have identified predictors of consistent BDR and determined that this phenotype is associated with poor clinical outcomes.

Indexed as

Administration, InhalationAdrenergic beta-AgonistsAsthmaBronchodilator AgentsBudesonideChildDouble-Blind MethodFemaleHumansMaleNedocromilSpirometryTreatment OutcomeVital CapacityAdrenergic beta-AgonistsBronchodilator AgentsBudesonideNedocromil

Identifiers

PMID18848350
PMCPMC2947830
OpenAlexW2068861734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.